Intended for healthcare professionals

News Extra [these Stories Appear Only On The Web]

WHO ultimatum on artemisinin monotherapy is showing results

BMJ 2006; 332 doi: (Published 18 May 2006) Cite this as: BMJ 2006;332:1176

Artemesinin monotherapy

I had a meeting with Dr.Andrea Bosman of WHO and he was of the
opinion that because the monotherapy is a 7day course compliance may be an
issue as opposed to the 3 days combo.He further asserted that 70m anti
malarial dosagess were administered in 2006 where as 1.5m cases were
reported as confirmed. The problem i feel with these statistics that form
the premise for their action to ban monotherapies is that most of the 70m
anti malarial dosages were non artemesinin derivatives. Secondly the 1.5m
confirmed cases are based on diagnostic laboratory reports which is highly
inaccurate. This is because due to the lack of diagnostic apparatus in
rural Pakistan, medication is prescribed solely on the basis of symptoms.
Banning montherapies is hardly the solution. In my opinion doctor and
patient education and creating a network of diagnostic laboratories would
have addressed the compliance issue more effectively.

Competing interests:
None declared

Competing interests: No competing interests

07 May 2007
Naveed Hakim
Managing Director
karachi, pakistan